Clinical and Cognitive Effects of Computer Assisted Cognitive Remediation Method in Turkish Men with Opioid Use Disorder: A Randomized Controlled Trial

References

• Albertella, L., Wagner, M., Still, M., & Ward, P. (2008). A randomızed controlled trıal of computerızed cognıtıve remedıatıon (Cogpack) ın an outpatıent sample of patıents wıth schızophrenıa spectrum dısorders. Schizophrenia Research, 102(1–3), 251. https://doi.org/10.1016/S0920-9964(08)70757-6
   Google Scholar
• Aşık, A. H., Yalınçetin, N., Kuloğlu, M. M., Canan, F., Yalnız, H., & Geçici, Ö. (2014). Predictors of relapse in patients with opioid addiction during buprenorphine–naloxone maintenance treatment. The American Journal on Addictions, 23(1), 62–67.
   Google Scholar
• Baldacchino, A., Balfour, D. J. K., Passetti, F., Humphris, G., & Matthews, K. (2012). Neuropsychological consequences of chronic opioid use: A quantitative review and meta-analysis. Neuroscience & Biobehavioral Reviews, 36(9), 2056–2068. https://doi.org/10.1016/j.neubiorev.2012.06.006
   PubMed Web of Science ®Google Scholar
• Barlas, L., Unubol, B., & Dag, I. (2021). Comparison of impulsivity with self-report and behavioural method in patients with opioid use disorder. Heroın Addıctıon & Related Clınıcal Problems, 23(5), 5–14.
   PubMed Web of Science ®Google Scholar
• Bickel, W. K., Marsch, L. A., Buchhalter, A. R., & Badger, G. J. (2008). Computerized behavior therapy for opioid-dependent outpatients: A randomized controlled trial. Experimental & Clinical Psychopharmacology, 16(2), 132–143. https://doi.org/10.1037/1064-1297.16.2.132
   PubMed Web of Science ®Google Scholar
• Bickel, W. K., Yi, R., Landes, R. D., Hill, P. F., & Baxter, C. (2011). Remember the future: Working memory training decreases delay discounting among stimulant addicts. Biological Psychiatry, 69(3), 260–265. https://doi.org/10.1016/j.biopsych.2010.08.017
   PubMed Web of Science ®Google Scholar
• Clark, R. E., Baxter, J. D., Aweh, G., O’Connell, E., Fisher, W. H., & Barton, B. A. (2015). Risk factors for relapse and higher costs among medicaid members with opioid dependence or abuse: Opioid agonists, comorbidities, and treatment history. Journal of Substance Abuse Treatment, 57, 75–80. https://doi.org/10.1016/j.jsat.2015.05.001
   PubMed Web of Science ®Google Scholar
• Eack, S. M., Hogarty, S. S., Bangalore, S. S., Keshavan, M. S., & Cornelius, J. R. (2016). Patterns of substance use during cognitive enhancement therapy: An 18-month randomized feasibility study. Journal of Dual Diagnosis, 12(1), 74–82. https://doi.org/10.1080/15504263.2016.1145778
   PubMed Web of Science ®Google Scholar
• Epir, S., & İskit, Ü. (1972). Wechsler Yetişkinler Zeka Ölçeği Türkçe Çevirisinin Ön Analizi Ve Üniversite Danışmanlık Merkezlerindeki Uygulama Potansiyeli. Hacettepe Sosyal Bilimler Derg, 4, 198–205.
   Google Scholar
• Evren, C., Karabulut, V., Can, Y., Bozkurt, M., Umut, G., & Evren, B. (2014). Predictors of outcome during a 6-month follow-up among heroin dependent patients receiving buprenorphine/naloxone maintenance treatment. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 24(4), 311–322. https://doi.org/10.5455/bcp.20140310072258
   Web of Science ®Google Scholar
• Fiellin, D. A., Barry, D. T., Sullivan, L. E., Cutter, C. J., Moore, B. A., O’Connor, P. G., & Schottenfeld, R. S. (2013). A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine. The American Journal of Medicine, 126(1), 74.E11–74.E17. https://doi.org/10.1016/j.amjmed.2012.07.005
   PubMed Web of Science ®Google Scholar
• Hekmat, S., Alam Mehrjerdi, Z., Moradi, A., Ekhtiari, H., & Bakhshi, S. (2011). Cognitive flexibility, attention and speed of mental processing in opioid and methamphetamine addicts in comparison with non-addicts. Autonomous Neuroscience, 2, 12–19.
   Google Scholar
• Keshavan, M. S., Vinogradov, S., Rumsey, J., Sherrill, J., & Wagner, A. (2014). Cognitive training in mental disorders: update and future directions. The American Journal of Psychiatry, 171(5), 510–522. https://doi.org/10.1176/appi.ajp.2013.13081075
   PubMed Web of Science ®Google Scholar
• Kim, E. J., Bahk, Y.-C., Oh, H., Lee, W.-H., Lee, J.-S., & Choi, K.-H. (2018). Current status of cognitive remediation for psychiatric disorders: A review. Frontiers in Psychiatry, 9, 461. https://doi.org/10.3389/fpsyt.2018.00461
   PubMed Web of Science ®Google Scholar
• Kirby, K. N., Petry, N. M., & Bickel, W. K. (1999). Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. Journal of Experimental Psychology: General, 128(1), 78–87. https://doi.org/10.1037/0096-3445.128.1.78
   PubMed Web of Science ®Google Scholar
• Krupitsky, E., Zvartau, E., Blokhina, E., Verbitskaya, E., Wahlgren, V., Tsoy-Podosenin, M., Bushara, N., Burakov, A., Masalov, D., Romanova, T., Tyurina, A., Palatkin, V., Slavina, T., Pecoraro, A., & Woody, G. E. (2012). Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence. Archives of General Psychiatry, 69(9), 973–981. https://doi.org/10.1001/archgenpsychiatry.2012.1a
   PubMed Web of Science ®Google Scholar
• Kulaksizoglu, B., Kara, H., Ozcelik, O., & Kuloglu, M. (2019). The use of naltrexone implants for the treatment of opioid addiction: a retrospective study/opioid Bagimliliginin Tedavisinde Naltrekson İmplant Kullanimi: Geriye Donuk Bir Carisma. Anadolu Psikiyatri Dergisi, 20, 133.
   Google Scholar
• Lystad, J. U., Falkum, E., Haaland, V. Ø., Bull, H., Evensen, S., Mcgurk, S. R., & Ueland, T. (2017). Cognitive remediation and occupational outcome in schizophrenia spectrum disorders: A 2 year follow-up study. Schizophrenia Research, 185, 122–129. https://doi.org/10.1016/j.schres.2016.12.020
   PubMed Web of Science ®Google Scholar
• Ma, B., Mei, D., Wang, F., Liu, Y., & Zhou, W. (2019). Cognitive enhancers as a treatment for heroin relapse and addiction. Pharmacological Research, 141, 378–383. https://doi.org/10.1016/j.phrs.2019.01.025
   PubMed Web of Science ®Google Scholar
• Marceau, E. M., Berry, J., Lunn, J., Kelly, P. J., & Solowij, N. (2017). Cognitive remediation improves executive functions, self-regulation and quality of life in residents of a substance use disorder therapeutic community. Drug & Alcohol Dependence, 178, 150–158. https://doi.org/10.1016/j.drugalcdep.2017.04.023
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., Breen, C., Kimber, J., Davoli, M., & Breen, R. (2003a). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, 2003, (2), CD002209. https://doi.org/10.1002/14651858.cd002209
   Google Scholar
• Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2003b). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, (2). Art. No.: CD002207 https://doi.org/10.1002/14651858.cd002207.pub2
   Google Scholar
• Moore, B. A., Fiellin, D. A., Cutter, C. J., Buono, F. D., Barry, D. T., Fiellin, L. E., O’Connor, P. G., & Schottenfeld, R. S. (2016). Cognitive behavioral therapy ımproves treatment outcomes for prescription opioid users in primary care buprenorphine treatment. Journal of Substance Abuse Treatment, 71, 54–57. https://doi.org/10.1016/j.jsat.2016.08.016
   PubMed Web of Science ®Google Scholar
• Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal cognitive assessment, Moca: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
   PubMed Web of Science ®Google Scholar
• Norman, G. (2010). Likert scales, levels of measurement and the “laws” of statistics. Advances in Health Sciences Education: Theory & Practice, 15(5), 625–632. https://doi.org/10.1007/s10459-010-9222-y
   PubMed Web of Science ®Google Scholar
• Ögel, K., Evren, C., Karadağ, F., & Gürol, D. T. (2012). The development, validity, and reliability of the addiction profile ındex (API). Turk Psikiyatri Dergisi = Turkish Journal of Psychiatry, 23(4), 263–275.
   PubMed Web of Science ®Google Scholar
• Passetti, F., Clark, L., Mehta, M. A., Joyce, E., & King, M. (2008). Neuropsychological predictors of clinical outcome in opiate addiction. Drug & Alcohol Dependence, 94(1–3), 82–91. https://doi.org/10.1016/j.drugalcdep.2007.10.008
   PubMed Web of Science ®Google Scholar
• Prosser, J., Cohen, L. J., Steinfeld, M., Eisenberg, D., London, E. D., & Galynker, I. I. (2006). Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug & Alcohol Dependence, 84(3), 240–247. https://doi.org/10.1016/j.drugalcdep.2006.02.006
   PubMed Web of Science ®Google Scholar
• Rass, O., Schacht, R. L., Buckheit, K., Johnson, M. W., Strain, E. C., & Mintzer, M. Z. (2015). A randomized controlled trial of the effects of working memory training in methadone maintenance patients. Drug & Alcohol Dependence, 156, 38–46. https://doi.org/10.1016/j.drugalcdep.2015.08.012
   PubMed Web of Science ®Google Scholar
• Rezapour, T., Devito, E. E., Sofuoglu, M., & Ekhtiari, H. (2016). Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders: from cognitive improvement to relapse prevention. Progress in Brain Research, 224, 345–369.
   PubMed Web of Science ®Google Scholar
• Rezapour, T., Hatami, J., Farhoudian, A., Sofuoglu, M., Noroozi, A., Daneshmand, R., Samiei, A., & Ekhtiari, H. (2019). Cognitive rehabilitation for individuals with opioid use disorder: A randomized controlled trial. Neuropsychological Rehabilitation, 29(8), 1273–1289. https://doi.org/10.1080/09602011.2017.1391103
   PubMed Web of Science ®Google Scholar
• Rupp, C. I., Kemmler, G., Kurz, M., Hinterhuber, H., & Fleischhacker, W. W. (2012). Cognitive remediation therapy during treatment for alcohol dependence. Journal of Studies on Alcohol & Drugs, 73(4), 625–634. https://doi.org/10.15288/jsad.2012.73.625
   PubMed Web of Science ®Google Scholar
• Selekler, K., Cangöz, B., & Uluç, S. (2010). Power of discrimination of Montreal Cognitive Assessment (Moca) Scale in Turkish patients with mild cognitive impairement and Alzheimer’s disease. Turk Geriatri Derg, 166, 171.
   Google Scholar
• Stein, M. D., Cioe, P., & Friedmann, P. D. (2005). Brief report: Buprenorphine retention in primary care. Journal of General Internal Medicine, 20(11), 1038–1041. https://doi.org/10.1111/j.1525-1497.2005.0228.x
   PubMed Web of Science ®Google Scholar
• Sofuoglu, M., Devito, E. E., Waters, A. J., & Carroll, K. M. (2013). Cognitive enhancement as a treatment for drug addictions. Neuropharmacology, 64, 452–463. https://doi.org/10.1016/j.neuropharm.2012.06.021
   PubMed Web of Science ®Google Scholar
• Tamam, L., Güleç, H., & Karataş, G. (2013). Short Form of Barratt Impulsiveness Scale (BIS-11-SF) Turkish adaptation study/Barratt Durtusellik Olcegi Kisa Formu (Bıs-11-Kf) Turkce Uyarlama Calismasi. Nöro Psikiyatri Arşivi, 50(2), 130–134. [Mismatch] https://doi.org/10.4274/npa.y6296
   Google Scholar
• United Nations Office on Drugs and Crime (2019). World drug report 2019. World Drug Report. https://doi.org/10.18356/a4dd519a-en
   Google Scholar
• Wechsler, D. (1997). Scale-Revised, WAI. The Psychological Corporation.
   Google Scholar
• Wise, R. A., & Koob, G. F. (2014). The development and maintenance of drug addiction. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 39(2), 254–262. https://doi.org/10.1038/npp.2013.261
   PubMed Web of Science ®Google Scholar
• Wykes, T., Huddy, V., Cellard, C., Mcgurk, S. R., & Czobor, P. (2011). A meta-analysis of cognitive remediation for schizophrenia: Methodology and effect sizes. American Journal of Psychiatry, 168(5), 472–485. https://doi.org/10.1176/appi.ajp.2010.10060855
   PubMed Web of Science ®Google Scholar